Relationship Between Hepcidin, Iron Metabolism, Inflammation and Hypersplenism in Anaemia of Kala‐Azar
Parasite Immunology · 2025
DOI: 10.1111/pim.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasite Immunology, 2025. Verfasst von Alyne Ferreira De Almendra Freitas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Health and Science, Federal University of Piauí, Teresina, Piauí, Brazil. Hauptthemen laut MEDLINE: Hepcidins, Leishmaniasis, Visceral, Anemia, Iron. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq.
Abstract (Originalsprache)
Kala‐azar, or visceral leishmaniasis (VL), is a parasitic disease caused by Leishmania spp., characterised by fever, weight loss, splenomegaly, hepatomegaly, and anaemia. This study evaluated the relationship between hepcidin, inflammation, iron metabolism, and hypersplenism in VL‐associated anaemia. In this cross‐sectional study, confirmed VL patients without recent transfusions were assessed. Haematological and inflammatory parameters were analysed using correlation and multivariate regression tests. Anaemia was present in 95.2% of the sample, predominantly normocytic (59.5%) and normochromic (76.2%), or microcytic (40.5%) and hypochromic (23.8%). Inflammatory markers were markedly elevated in most patients, particularly hepcidin, which was increased in 97.6% of cases (median: 351.46 ng/mL), suggesting persistent inflammation and impaired iron bioavailability. However, IL‐6, CRP, and ferritin showed weak to moderate negative correlations with hepcidin ( ρ = −0.33, ρ = −0.66, and ρ = −0.30, respectively). These findings highlight the complex interplay between anaemia and inflammation in kala‐azar, with elevated hepcidin levels and paradoxical correlations with inflammatory markers. They underscore the central role of splenomegaly in VL‐related anaemia and suggest potential contributions from other factors affecting iron metabolism, such as erythropoietin and erythroferrone. Understanding the dynamics of these markers throughout disease progression and treatment may further elucidate the pathophysiology of VL and support the development of targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Health and Science, Federal University of Piauí, Teresina, Piauí, Brazil.
- Leishmaniasis Research Laboratory - LabLeish, Piauí, Brazil.
- Dr. Costa Alvarenga Central Public Health Laboratory (LACEN), Teresina, Piauí, Brazil.
- Federal University of Piauí, Teresina, Piauí, Brazil.
- Center for Intelligence on Emerging and Neglected Tropical Diseases (CIATEN), Teresina, Piauí, Brazil.
- Federal University of Paraíba, João Pessoa, Paraíba, Brazil.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- CNPq
Zitieren
APA
Freitas, A. F. A., Neto, A. S. L., de Moura, C. M. C., Silva, G. D., Silva, M. S. A. B. E., Vilges, K. M. A., Ferreira, F. M. A. M., Costa, D. L., & Costa, C. H. N. (2025). Relationship Between Hepcidin, Iron Metabolism, Inflammation and Hypersplenism in Anaemia of Kala‐Azar. Parasite Immunology. https://doi.org/10.1111/pim.70014
Vancouver
Freitas AFA, Neto ASL, de Moura CMC, Silva GD, Silva MSABE, Vilges KMA, et al. Relationship Between Hepcidin, Iron Metabolism, Inflammation and Hypersplenism in Anaemia of Kala‐Azar. Parasite Immunology. 2025. doi:10.1111/pim.70014
BibTeX
@article{Freitas2025,
author = {Freitas, Alyne Ferreira De Almendra and Neto, Adelino Soares Lima and de Moura, Camila Maria Coelho and Silva, Giovana Dias and Silva, Marília de Sousa Araújo Barbosa E and Vilges, Keline Medeiros de Araújo and Ferreira, Francisco Mateus Alves de Morais and Costa, Dorcas Lamounier and Costa, Carlos Henrique Nery},
title = {Relationship Between Hepcidin, Iron Metabolism, Inflammation and Hypersplenism in Anaemia of Kala‐Azar},
journal = {Parasite Immunology},
year = {2025},
doi = {10.1111/pim.70014}
}
EUVIMED